GENE ONLINE|News &
Opinion
Blog

China
China’s Abogen Raises $700M to Fund the First Homegrown mRNA COVID-19 Vaccine to Enter Human Trial
2021-08-20
Innovent Announces Gastric Cancer Trial Win for Tyvyt, Reveals Plans for Another China Approval
2021-08-16
China Allows Trials to Evaluate Mixing and Matching of INOVIO, Sinovac Vaccines
2021-08-10
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
China’s Everest Medicines Partners with Tech Giant Tencent to Develop Digital Healthcare Ecosystem
2021-07-16
China’s Brii Bio Raises $319 million in the Hong Kong IPO
2021-07-16
COVID-19: Foxconn and TSMC Closes Deal to Secure 10 Million Pfizer Vaccines for Taiwan
2021-07-13
Sparx Therapeutics to Build a Massive Manufacturing Plant in China for Multi-Specific Antibody Production
2021-07-10
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
China’s Legend Biotech to Build a CAR-T Therapy Production Site in Belgium
2021-06-24
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
COVID-19: WHO Grants Worldwide Emergency Use Approval for First Chinese Vaccine
2021-05-10
AstraZeneca, Geneseeq Sign Collaborative Deal to Build Bio Center in China
2021-04-29
How Does China Tackle the Issue of Patent Protection? A Deepdive into China’s Patent Trends
2021-03-19
1 3 4 5 6 7 8
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top